483 AstraZeneca Pharmaceuticals, LP Jul 2011

483 AstraZeneca Pharmaceuticals, LP Jul 2011

Anita Michael FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals, LP - Newark, DE, United States facility and issued 1 inspectional observation (via FDA 483) on 05 Jul 2011.

Product details

  • Category: Human Drugs
  • Number of Observations: 1
  • Inspection end: 05 Jul 2011
  • Location: Newark, United States
  • FEI: 2517100
Add To Cart